Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study
about
Resveratrol: A potential challenger against gastric cancerUnraveling the Anticancer Effect of Curcumin and ResveratrolDrug delivery systems, CNS protection, and the blood brain barrierResveratrol: review on therapeutic potential and recent advances in drug delivery.Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis.Resveratrol as a therapeutic agent for Alzheimer's disease.Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of conceptNanoscale Delivery of Resveratrol towards Enhancement of Supplements and NutraceuticalsA healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations.Microsponges: a futuristic approach for oral drug delivery.Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol.Cyclodextrin based nanosponges for pharmaceutical use: a review.Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.The application of nanosponges to cancer drug delivery.Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia.Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?Delivery aspects of antioxidants in diabetes management.Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development.Tuning structural parameters for the optimization of drug delivery performance of cyclodextrin-based nanosponges.Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrolCross-linked poly(acrylic acids) microgels and agarose as semi-interpenetrating networks for resveratrol release.Photophysics and ex vivo biodistribution of β-cyclodextrin-meso-tetra(m-hydroxyphenyl)porphyrin conjugate for biomedical applications.Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs.Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory PhytocompoundsCyclodextrin-based nanosponges as drug carriers.Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery.The Role of Resveratrol in Cancer Therapy.Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate.Rutin-phospholipid complex in polymer matrix for long-term delivery of rutin via skin for the treatment of inflammatory diseases.Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation.PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes.New Water-Soluble Carbamate Ester Derivatives of Resveratrol
P2860
Q26784390-FF3FC8FE-16A9-4802-9EA0-0082D9D42457Q28073155-929F2FE6-06AD-4CCF-9445-AA560FC50BA7Q30432845-DA86C3A6-D98D-4C6C-9BFD-B0AC93F0D5BEQ34420121-43B72813-C1C5-4AAD-BA15-C4BAAAAF1290Q34434218-FA94A221-B995-4B94-8D3C-D06BD73F9BDEQ34667472-F8512057-DC0B-4D92-B30B-4B1444A713DBQ35108724-52967AD2-2734-43EB-9124-AE0C97F65D8EQ36732033-154DDB52-5ED0-4135-811B-1501C6E6EEA0Q37152779-8613516A-4306-440E-B18C-D96C97FF7E64Q38015898-46997409-45DD-431B-8312-948F29CBC0D9Q38017320-FEFB8E31-4990-4A0D-9CEE-EA6CF583A1DFQ38121603-3975EE89-29CB-4689-A249-DA4CB380A05CQ38155019-FFCB3664-4117-4AC7-9F79-3BCF114F3536Q38168259-AD2F784B-181F-420A-A7B9-74EFAF08BB03Q38210423-401398C9-C727-46E5-9408-27E0F79AD3B7Q38218145-3A24B56E-5C05-40DC-B224-DF6A833472FFQ38262965-057701FF-93B7-47CE-8AC0-5D7DDAC1A4A7Q38315902-E4D5496A-B0A0-4C9F-A364-5B20B1DC4368Q38708186-6B8DF479-1851-4313-AA3B-C08821CBE7EAQ38905957-C7DC7E6A-2438-4183-B20A-8E1693531BD7Q38918022-22A60AC0-5B0D-4DB7-8427-5851F4DFB113Q38921280-8348AB9D-1E97-4569-B14C-754829CF3405Q38983195-D6BE0B03-E014-4A31-98E6-7721B605CBA5Q39145487-AE858026-740E-4965-B78F-AE11F56AAC78Q39204729-5B8461CF-EF98-4B9C-B6B8-CC7D94CFACA7Q41903071-CFFAD6CB-B280-4E9E-8DB3-EBF58BFCA4FBQ45743284-CDD16F1C-4AA1-4121-B673-A73485D661C8Q47940580-37619A1C-3203-4CC8-A6F7-F706968A97CCQ48002651-F5EF72FF-BAD4-4C8D-B30E-190F3B9D0E99Q49954588-461B5FB5-60C5-4D0A-B2A7-BEC4DBF56CBDQ50494692-744145E4-E776-4D27-92EA-67AE4730F47EQ51358876-D2A3AFC4-36A8-4F43-8B03-6A05B987C08FQ57974104-4B718867-E9F9-4453-9D8E-EFA205DCEE77
P2860
Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@ast
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@en
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@nl
type
label
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@ast
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@en
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@nl
prefLabel
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@ast
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@en
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@nl
P2093
P2860
P1433
P1476
Cyclodextrin-based nanosponges ...... otoxicity and permeation study
@en
P2093
Francesco Trotta
Khalid A Ansari
Pradeep R Vavia
Roberta Cavalli
P2860
P2888
P304
P356
10.1208/S12249-011-9584-3
P407
P577
2011-03-01T00:00:00Z
P5875
P6179
1006016490